All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL)

Hematological Oncology

Volumn 14, Issue 3, 1996, Pages 147-154

  Chim, C S ^a,b   Kwong, Y L ^a   Liang, R ^a   Chu, Y C ^b   Chan, C H ^b   Chan, L C ^a   Wong, K F ^b   Chan, T K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

acute promyelocytic leukemia; all trans retinoic acid; event free survival

Indexed keywords

CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MITOXANTRONE; RETINOIC ACID; TIOGUANINE;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COHORT STUDIES; CYTARABINE; DAUNORUBICIN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; LIFE TABLES; MALE; MIDDLE AGED; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; PROSPECTIVE STUDIES; REMISSION INDUCTION; SALVAGE THERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TRETINOIN;

EID: 0030424531     PISSN: 02780232     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1069(199609)14:3<147::AID-HON582>3.0.CO;2-3     Document Type: Article

References (22)

1. Bennet, J. M., Catowsky, D., Danier, M. T., et al. A variant form of hyopergranular promelocytic leukemia (M3). Ann. Intern. Med. 1980, 92, 280.
2. Jones, M. E., Saleem, A. Acute promyelocytic leukemia: A review of literature. Am. J. Med. 1978, 65, 674.
3. Tallman, M. S., Kwaan, H. C. Reassessing the hemostatic disorder associated with acute promyelocytic leukemia. Blood 1992, 79, 543.
4. Larson, R. A., Kondo, K., Vardiman, J. W., Butler, A. R. E., Golomb, H. M., Rowley, J. D. Evidence for 1 15;17 translocation in every patient with acute promyelocytic leukemia. Am. J. Med. 1984, 76, 827.
5. De The, H., Chomienne, C., Lanotte, M., Degos, L., Dijean, A. The t(15;17) translocation of acute promvelocytic leukemia fuses the retinoic acid receptor a gene to a novel transcribed locus. Nature 1990, 347, 558.
6. Kakizuka, A., Miller, W. H., Umesono, Ek., et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 1991, 66, 663.
7. Breitman, T. R., Selonick, S. E., Collins, S. J. Induction of differentition of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. U.S.A. 1980, 77, 2936-2940.
8. Huang, M., Yu-Chen, Y., Shu-Rong, C., et al. Use of All-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988, 72, 567.
9. Cordonnier, C., Vernant, J. P., Brun, B. Acute promyelocytic leukemia in 57 previously untreated patients. Cancer 1985, 55, 18.
10. Goldberg, M. A., Ginsburg, D., Mayer, R. J., et al. Is heparin necessary during induction chemotherapy for patients with acute promyelocytic leukemia? Blood 1987, 69, 187.
11. Kantarjian, H. M., Keating, M. J., Walters, R. S., Smith, T. L., McCredie, K. B., Freireich, E. J. Role of maintenance chemotherapy in acute promyelocytic leukemia. Cancer 1987, 59, 1258.
12. Head, D. R., Kopecky, K. J., Willman, C., Appelbaum, F. R. Treatment outcome with chemotherapy in acute promyelocytic leukemia: The southwest oncology group (SWOG) experience. Leukemia 1994, 8(suppl. 2), S38.
13. Degos, L., Dombret, H., Chomienne, C., et al. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood 1995, 85, 2643.
14. Frankel, S. R., Eardley, A., Heller, G., et al. All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York study. Ann. Intern. Med. 1994, 120, 279.
15. Chen, Z. X., Yue, Y. O., Zhang, R., et al. A clinical and experimental study on All-trans retinoic acid treated acute promyelocytic leukemia patients. Blood 1991, 78, 1413.
16. Wang, Z. Y., Sun, G. L., Lu, J. X., Gu, L. J., Huang, M. F., Chen, S. R. Treatment of acute promyelocytic leukemia with all-trans retinoic acid in China. Nouv. Rev. Fr. Hematol. 1990, 32, 34.
17. Degos, L., Chomienne, C., Daniel, M. T., et al. Treatment of first relapse in acute promyelocytic leukemia with All-trans retinoic acid. Lancet 1990, ii, 1440.
18. Fenaux, P., Castaigne, S., Dombret, H., et al. All-trans retinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: A pilot study on 26 cases. Blood 1992, 80, 2176.
19. Kanamaru, A., Takemoto, Y., Tanimoto, M., et al. Japan Adult Leukemia Study Group. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Blood 1995, 85, 1202.
20. Warrell, R. P., Maslak, P., Eardley, A., Heller, G., Miller, W. H., Frankel, S. R. Treatment of acute promyelocytic leukemia with all-trans retinoic acid: An update of the New York experience. Leukemia 1994, 8, 926.
21. Fenaux, P., Le Deley, M. C., Castaigne, S., et al. The European APL 91 Group. Effect of All-transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. Blood 1993, 82, 3241.
22. Tallman, M. S., Andersen, J., Schiffer, C. A., et al. For the ECOG, CALBG, SWOG, CCSG, POG and NCIC-CTG. Phase III randomized study of all-trans retinoic acid (promyelocytic leukemia) Vs daunorubicin (D) and cytosine arabinoside (A) as induction therapy and promyelocytic leukemia Vs observation as maintenance therapy for patients with previously untreated acute promyelocytic leukemia (APL). Blood 1995, 86(10) (suppl. 1), 125a.